Results for tag: "Sarcoidosis Drug"

The Sarcoidosis Drug market is a subset of the larger Respiratory Drugs market. Sarcoidosis is a chronic inflammatory disease that affects multiple organs, most commonly the lungs. Treatment for sarcoidosis is typically focused on managing symptoms and preventing organ damage. Commonly prescribed drugs include corticosteroids, immunosuppressants, and biologics. Corticosteroids are the most commonly prescribed drug for sarcoidosis, and are used to reduce inflammation and suppress the immune system. Immunosuppressants are used to reduce inflammation and prevent organ damage, while biologics are used to target specific proteins that are involved in the inflammatory process. Some companies in the Sarcoidosis Drug market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more